mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.5 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.5 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |